The Broncos took a then-record $85 million dead money hit by parting with Wilson in 2024, but their quick turnaround has ...

Big pharma is hunting again, and patent cliffs are forcing buyers to overpay or miss out. Three mid-cap biotechs have quietly ...

Big pharma’s appetite for clinical-stage biotech is back. The pending acquisition of Apogee Therapeutics by AbbVie (NYSE: ...

Indian IT faces potential FY27 revenue cuts due to AI spending shifts, geopolitical risks, and uncertain demand conditions.

On a recent Diet TBPN segment, John Coogan and callers Quinn Thompson and Nick Carter spent a chunk of the show trying to ...

From traditional jerseys to modern classics, here are the teams that will look the best on the field this season. Literally.

Indian professionals are rethinking the H-1B route as US visa backlogs, exploitative consultancies, wage theft and ...

There were few surprises in the first round of the draft, but a flurry of late moves show how desperate teams are to avoid ...

Picture a solo consultant, a freelance contractor, or the owner of a small S-corp who clears $184,500 or more in net self-employment income. They already write the biggest Social Security check of ...

Opinion: Accenture’s outlook is only one marker. While markets may have overreacted, it points to a turbulent AI-driven phase ...

Pro Football Focus left of Chris Johnson from the Tennessee Titans All-20-Year team, and he's not alone as a snub from the list of deserving players.

Lionel Messi's double pushed Argentina past Austria and into the knockout rounds of the 2026 World Cup as the team's title ...